comparemela.com
Home
Live Updates
Mixed Results for Factor Xa Reversal Agent in ICH: ANNEXA-I : comparemela.com
Mixed Results for Factor Xa Reversal Agent in ICH: ANNEXA-I
Full results of the ANNEXA-I trial, showing better control of hematoma expansion but an increase in thrombotic events with andexanet vs usual care, are now published in NEJM.
Related Keywords
San Francisco ,
California ,
United States ,
Canada ,
Andexxa Ondexxya ,
Claude Hemphill ,
Stuart Connolly ,
Wade Smith ,
Mcmaster University ,
University Of California ,
National Institutes Of Health Stroke Scale ,
Astrazeneca ,
New England Journal ,
National Institutes ,
Health Stroke Scale ,
comparemela.com © 2020. All Rights Reserved.